Showing 2251-2260 of 7583 results for "".
Neuromodulators and Dermal Fillers: Dr. Gold
https://practicaldermatology.com/programs/practical-dermatology/neuromodulators-and-dermal-fillers-dr-gold/32694/Michael Gold, MD, talks about the new neurotoxins and applications, as well as fillers, that he covered during "Neuromodulators and Dermal Fillers: What's New, What's Coming and What Are We Doing That's New in 2025" at Maui Derm 2025.How to Combine Injectables with Light- and Energy-Based Devices
https://practicaldermatology.com/conferences/maui-derm-2024/how-to-combine-injectables-with-light-and-energy-based-devices/20238/Beverly Hills cosmetic dermatologist Ava Shamban, MD, shares her expertise on using hyaluronic acid on the lateral side of the face to help fight “filler fatigue” in patients. “You can see it in the before and afters because of that glide plane lateral to the line of ligaments.”2022 in Review
https://practicaldermatology.com/topics/other-dermatology/2022-in-review/23833/The past year brought many new approvals and advances to dermatology for improved patient care.Dermatology Innovations
https://practicaldermatology.com/topics/psoriasis/dermatology-innovations/20044/From topical therapies to JAK inhibitors, there are many new drugs available to treat a wide variety of dermatologic conditions. Neal Bhatia, MD reviews what's new for atopic dermatitis, alopecia areata, scabies, lice, onychomycosis, and more. Plus, he discusses the importance of new delivery systemThree Essential Steps to YouTube Marketing Success
https://practicaldermatology.com/topics/practice-management/three-essential-steps-to-youtube-marketing-success/23626/Apply basic marketing strategies—plus some of YouTube’s unique principles—to market your practice.DermWireTV: 2020 in Review
https://practicaldermatology.com/topics/psoriasis/dermwiretv-2020-in-review/19882/Crisaborole ointment became the first and only steroid-free, topical prescription medication for mild to moderate AD in patients as young as three months of age. Ustekinumab is approved for pediatric patients with moderate to severe plaque psoriasis. FDA approved ixekizumab injection, 80mg/mL for tPsoriasis Comorbidities
https://practicaldermatology.com/topics/psoriasis/psoriasis-comorbidities/19729/Do you assess the gums of patients with psoriasis? Joel Gelfand, MD explains why periodontal disease may be underappreciated for what it contributes to the psoriatic disease process.Modifying Masseters and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/modifying-masseters-and-more/19698/Artful use of neurotoxin in the masseters and parotid glands can help thin the appearance of the face. Chytra Anand, MD discusses her approach and talks about treatments used in her home country of India.Psoriasis Risk Factors and Comorbidities
https://practicaldermatology.com/topics/psoriasis/psoriasis-risk-factors-and-comorbidities/19650/Ronald Prussick, MD outlines known risk factors for developing psoriasis, such as genetic factors, smoking, alcohol consumption, and increased BMI, and recent studies that confirm these risks. He also shares data on comorbidities, including the patients with psoriasis are more prone to pathologic frBeautiFill™: One Step Fat Transfer Solution
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/beautifill-one-step-fat-transfer-solution/19550/Sponsored by Alma